BR112016003082A8 - uso da tropoelastina na produção de um medicamento para cicatrização de uma ferida ou para melhora da reepitelização de uma ferida - Google Patents
uso da tropoelastina na produção de um medicamento para cicatrização de uma ferida ou para melhora da reepitelização de uma ferida Download PDFInfo
- Publication number
- BR112016003082A8 BR112016003082A8 BR112016003082A BR112016003082A BR112016003082A8 BR 112016003082 A8 BR112016003082 A8 BR 112016003082A8 BR 112016003082 A BR112016003082 A BR 112016003082A BR 112016003082 A BR112016003082 A BR 112016003082A BR 112016003082 A8 BR112016003082 A8 BR 112016003082A8
- Authority
- BR
- Brazil
- Prior art keywords
- wound
- tropoelastine
- reepithelization
- heal
- medicine
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 206010052428 Wound Diseases 0.000 abstract 3
- 208000027418 Wounds and injury Diseases 0.000 abstract 3
- 102100033167 Elastin Human genes 0.000 abstract 2
- 108010014258 Elastin Proteins 0.000 abstract 2
- 229920002549 elastin Polymers 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 230000017423 tissue regeneration Effects 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0203—Adhesive bandages or dressings with fluid retention members
- A61F13/0213—Adhesive bandages or dressings with fluid retention members the fluid retention member being a layer of hydrocolloid, gel forming material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3633—Extracellular matrix [ECM]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Zoology (AREA)
- Dispersion Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Botany (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
resumo patente de invenção para "regeneração de tecido danificado" um método de cicatrização de uma ferida, incluindo o contato de uma borda da ferida com um peptídeo derivado de tropoelastina ou elastina em condições que permitem um contato prolongado da tropoelastina com a borda da ferida durante um período de tempo para permitir a reepitelização da ferida.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2013903092A AU2013903092A0 (en) | 2013-08-13 | Regeneration of damaged tissue | |
PCT/AU2014/050180 WO2015021508A1 (en) | 2013-08-13 | 2014-08-13 | Regeneration of damaged tissue |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112016003082A2 BR112016003082A2 (pt) | 2017-08-01 |
BR112016003082A8 true BR112016003082A8 (pt) | 2020-01-28 |
Family
ID=52467858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112016003082A BR112016003082A8 (pt) | 2013-08-13 | 2014-08-13 | uso da tropoelastina na produção de um medicamento para cicatrização de uma ferida ou para melhora da reepitelização de uma ferida |
Country Status (12)
Country | Link |
---|---|
US (3) | US20160194379A1 (pt) |
EP (2) | EP3033099B1 (pt) |
JP (3) | JP6382311B2 (pt) |
KR (3) | KR20230004965A (pt) |
CN (2) | CN110464837A (pt) |
AU (3) | AU2014306362B2 (pt) |
BR (1) | BR112016003082A8 (pt) |
CA (1) | CA2920312C (pt) |
ES (1) | ES2965893T3 (pt) |
MX (2) | MX2016001436A (pt) |
RU (1) | RU2677637C2 (pt) |
WO (1) | WO2015021508A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014063194A1 (en) | 2012-10-23 | 2014-05-01 | The University Of Sydney | Elastic hydrogel |
EP3821918A1 (en) | 2012-12-10 | 2021-05-19 | Allergan Pharmaceuticals International Limited | Scalable three-dimensional elastic construct manufacturing |
CN110464837A (zh) | 2013-08-13 | 2019-11-19 | 爱力根制药国际有限公司 | 受损组织的再生 |
CN107921100A (zh) * | 2015-09-01 | 2018-04-17 | 埃拉斯塔根私人有限公司 | 骨形成 |
US20190275204A1 (en) * | 2016-11-04 | 2019-09-12 | Elastagen Pty Ltd | Biosynthetic devices |
US20200345623A1 (en) * | 2019-05-03 | 2020-11-05 | Allergan Pharmaceuticals International Limited | Methods of scar prevention and/or treatment |
WO2022076117A1 (en) * | 2020-09-08 | 2022-04-14 | Protein Genomics Inc. | Biomimetic wound healing devices and related methods of treating diabetic wounds |
Family Cites Families (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4675387A (en) | 1985-07-26 | 1987-06-23 | E. I. Du Pont De Nemours And Company | Method for extracting protein with organic acid |
US5260203A (en) | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
US4947840A (en) | 1987-08-21 | 1990-08-14 | Massachusetts Institute Of Technology | Biodegradable templates for the regeneration of tissues |
ES2052027T5 (es) | 1988-11-11 | 2005-04-16 | Medical Research Council | Clonacion de secuencias de dominio variable de inmunoglobulina. |
AU645794B2 (en) | 1990-03-30 | 1994-01-27 | Shiseido Company Ltd. | Process for purifying polypeptide |
DE69334287D1 (de) | 1992-09-25 | 2009-07-09 | Avipep Pty Ltd | Zielmoleküle-bindende Polypeptide bestehend aus einer IG-artigen VL Domäne die an eine IG-artige VH Domäne gebunden ist |
ATE412052T1 (de) | 1992-12-22 | 2008-11-15 | Univ Sydney | Synthetische polynukleotide |
US5726040A (en) | 1993-11-10 | 1998-03-10 | Ensley; Burt D. | Cosmetic compositions including tropoelastin isomorphs |
US7001328B1 (en) * | 1994-11-15 | 2006-02-21 | Kenton W. Gregory | Method for using tropoelastin and for producing tropoelastin biomaterials |
AUPO591797A0 (en) | 1997-03-27 | 1997-04-24 | Commonwealth Scientific And Industrial Research Organisation | High avidity polyvalent and polyspecific reagents |
US5969106A (en) | 1996-08-07 | 1999-10-19 | The Hospital For Sick Children | Self-aligning peptides modeled on human elastin and other fibrous proteins |
AUPO156596A0 (en) * | 1996-08-09 | 1996-09-05 | University Of Sydney, The | Synthetic polynucleotides |
AU737125B2 (en) | 1997-02-07 | 2001-08-09 | Kenton W. Gregory | Method for using tropoelastin and for producing tropoelastin biomaterials |
AUPO811797A0 (en) | 1997-07-18 | 1997-08-14 | University Of Sydney, The | Tropoelastin derivatives |
AU9313298A (en) | 1997-09-04 | 1999-03-22 | Point Biomedical Corporation | Injectable tissue reconstruction material |
AUPP472398A0 (en) | 1998-07-17 | 1998-08-13 | University Of Sydney, The | Protease susceptibility II |
US7465785B2 (en) | 1999-03-08 | 2008-12-16 | Genentech, Inc. | Polypeptide encoded by a nucleic acid over-expressed in melanoma |
CA2383539C (en) * | 1999-05-28 | 2007-12-04 | Kenton W. Gregory | Methods for producing laminated elastin, elastin-based materials and tropoelastin products for repairing and/or replacing tissue |
CA2685349C (en) | 1999-11-15 | 2013-09-17 | Bio Syntech Canada Inc. | Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution |
US20050244393A1 (en) | 1999-12-22 | 2005-11-03 | Henogen S.A. | Sealant or tissue generating product |
US6808707B2 (en) * | 2000-02-04 | 2004-10-26 | Matrix Design | Wound healing compositions and methods using tropoelastin and lysyl oxidase |
US20040110439A1 (en) | 2001-04-20 | 2004-06-10 | Chaikof Elliot L | Native protein mimetic fibers, fiber networks and fabrics for medical use |
WO2002096978A1 (fr) | 2001-05-30 | 2002-12-05 | Keiichi Miyamoto | Elastine reticulee et son procede de production |
AU2002952492A0 (en) | 2002-11-06 | 2002-11-21 | Cbio Limited | Chaperonin 10 immunosuppression |
US8038991B1 (en) | 2003-04-15 | 2011-10-18 | Abbott Cardiovascular Systems Inc. | High-viscosity hyaluronic acid compositions to treat myocardial conditions |
US8383158B2 (en) | 2003-04-15 | 2013-02-26 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
FR2855969B1 (fr) | 2003-06-13 | 2012-11-30 | Coletica | Stimulation de l'activite d'une isoforme de lysyl oxydase pour lutter contre certaines pathologies dues a une elastogenese incomplete, absente ou desorganisee |
FR2855968B1 (fr) | 2003-06-13 | 2012-11-30 | Coletica | Stimulation de la synthese et de l'activite d'une isoforme de la lysyl oxydase-like loxl pour stimuler la formation de fibres elastiques |
US8226715B2 (en) | 2003-06-30 | 2012-07-24 | Depuy Mitek, Inc. | Scaffold for connective tissue repair |
CA2562871C (en) | 2004-02-20 | 2014-06-10 | Human Matrix Sciences, Llc | Iron based compounds for elastogenesis and connective tissue treatment |
US7192043B1 (en) | 2004-05-25 | 2007-03-20 | Mcluen Design, Inc. | Multi-terrain wheel chair |
US7968085B2 (en) | 2004-07-05 | 2011-06-28 | Ascendis Pharma A/S | Hydrogel formulations |
US20060062768A1 (en) | 2004-09-23 | 2006-03-23 | Olexander Hnojewyj | Biocompatible hydrogel compositions |
WO2006098024A1 (ja) | 2005-03-16 | 2006-09-21 | Fujitsu Limited | Ipネットワークにおけるマルチキャストツリー監視方法およびシステム |
US20100233783A1 (en) | 2005-03-24 | 2010-09-16 | Straumann Holding Ag | Novel method for protein purification |
US8828433B2 (en) | 2005-04-19 | 2014-09-09 | Advanced Cardiovascular Systems, Inc. | Hydrogel bioscaffoldings and biomedical device coatings |
KR100785378B1 (ko) | 2005-09-05 | 2007-12-14 | 주식회사 바이오레인 | 다층구조의 유착방지제 |
WO2007048115A2 (en) | 2005-10-19 | 2007-04-26 | Gregory Kenton W | Method of using and producing tropoelastin and tropoelastin biomaterials |
US7770126B2 (en) | 2006-02-10 | 2010-08-03 | Microsoft Corporation | Assisting user interface element use |
US8518105B2 (en) | 2006-03-24 | 2013-08-27 | Abbott Cardiovascular System Inc. | Methods and apparatuses for coating a lesion |
US20070237735A1 (en) | 2006-03-31 | 2007-10-11 | Laboratoires Dermo-Cosmetik Inc. | Anti-aging composition, kit and method of use |
US8075920B2 (en) * | 2006-05-11 | 2011-12-13 | Regenics A/S | Administration of cells and cellular extracts for rejuvenation |
US20070287741A1 (en) | 2006-06-13 | 2007-12-13 | Uri Herzberg | Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals |
WO2008033847A2 (en) | 2006-09-11 | 2008-03-20 | Emory University | Modified protein polymers |
US7700126B2 (en) | 2006-09-29 | 2010-04-20 | Martin Kean Chong Ng | Tropoelastin-based protoelastin biomaterials |
US8101717B2 (en) * | 2006-11-13 | 2012-01-24 | The University Of Sydney | Use of tropoelastin for repair or restoration of tissue |
WO2009015372A1 (en) * | 2007-07-25 | 2009-01-29 | Dermaplus, Inc. | Photo-protective dermatological formulations and methods of using the same |
US8455459B2 (en) | 2007-08-02 | 2013-06-04 | Medicis Pharmaceutical Corporation | Method of applying an injectable filler |
FR2920968B1 (fr) | 2007-09-14 | 2009-11-13 | Oreal | Procede cosmetique de traitement esthetique et/ou reparateur de la peau |
WO2009099570A2 (en) | 2008-02-01 | 2009-08-13 | Wake Forest University Health Sciences | Aligned scaffolding system for skeletal muscle regeneration |
US8469961B2 (en) | 2008-03-05 | 2013-06-25 | Neville Alleyne | Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints |
US8940331B2 (en) | 2008-11-22 | 2015-01-27 | The Board Of Trustees Of The Leland Stanford Junior University | Hydrogels, methods of making hydrogels, methods of using hydrogels, and methods of isolating, trapping, attracting, and/or killing cancer cells |
US8080265B2 (en) | 2009-02-20 | 2011-12-20 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating signs of skin aging |
CN102348464B (zh) * | 2009-03-10 | 2016-05-25 | 悉尼大学 | 可注射生物材料 |
AU2011229730B2 (en) | 2010-03-22 | 2016-01-07 | Allergan, Inc. | Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation |
WO2011127478A1 (en) | 2010-04-09 | 2011-10-13 | Nanovasc, Inc. | Sleeve for graft and method |
US8658711B2 (en) | 2010-09-29 | 2014-02-25 | Rutgers, The State University Of New Jersey | Process for the synthesis of methacrylate-derivatized type-1 collagen and derivatives thereof |
WO2012068619A1 (en) | 2010-11-23 | 2012-05-31 | Elastagen Pty Ltd | Preparation and/or formulation of proteins cross-linked with polysaccharides |
GB201021438D0 (en) | 2010-12-16 | 2011-02-02 | Imp Innovations Ltd | Layered fibrous construct |
US9114128B2 (en) * | 2011-09-30 | 2015-08-25 | Protein Genomics, Inc. | Tropoelastins and uses thereof |
ES2729285T3 (es) | 2011-09-30 | 2019-10-31 | Allergan Pharmaceuticals Int Ltd | Síntesis in vivo de fibra elástica |
WO2014063194A1 (en) * | 2012-10-23 | 2014-05-01 | The University Of Sydney | Elastic hydrogel |
EP3821918A1 (en) | 2012-12-10 | 2021-05-19 | Allergan Pharmaceuticals International Limited | Scalable three-dimensional elastic construct manufacturing |
CN110464837A (zh) * | 2013-08-13 | 2019-11-19 | 爱力根制药国际有限公司 | 受损组织的再生 |
CN106068272B (zh) | 2013-09-24 | 2021-08-03 | 爱力根制药国际有限公司 | 提取蛋白质的方法 |
-
2014
- 2014-08-13 CN CN201910782833.0A patent/CN110464837A/zh active Pending
- 2014-08-13 CA CA2920312A patent/CA2920312C/en active Active
- 2014-08-13 EP EP14836821.0A patent/EP3033099B1/en active Active
- 2014-08-13 CN CN201480049722.4A patent/CN105530951B/zh active Active
- 2014-08-13 MX MX2016001436A patent/MX2016001436A/es active IP Right Grant
- 2014-08-13 EP EP23206907.0A patent/EP4316537A3/en active Pending
- 2014-08-13 KR KR1020227045816A patent/KR20230004965A/ko active IP Right Grant
- 2014-08-13 KR KR1020217040694A patent/KR102488446B1/ko active IP Right Grant
- 2014-08-13 ES ES14836821T patent/ES2965893T3/es active Active
- 2014-08-13 WO PCT/AU2014/050180 patent/WO2015021508A1/en active Application Filing
- 2014-08-13 BR BR112016003082A patent/BR112016003082A8/pt not_active Application Discontinuation
- 2014-08-13 JP JP2016533753A patent/JP6382311B2/ja active Active
- 2014-08-13 KR KR1020167005263A patent/KR20160041949A/ko not_active Application Discontinuation
- 2014-08-13 AU AU2014306362A patent/AU2014306362B2/en active Active
- 2014-08-13 RU RU2016104618A patent/RU2677637C2/ru active
- 2014-08-13 US US14/911,401 patent/US20160194379A1/en not_active Abandoned
-
2016
- 2016-01-29 MX MX2020011880A patent/MX2020011880A/es unknown
-
2018
- 2018-08-01 JP JP2018145202A patent/JP6639587B2/ja active Active
- 2018-10-24 US US16/169,908 patent/US11084867B2/en active Active
-
2019
- 2019-07-11 AU AU2019204972A patent/AU2019204972B2/en active Active
- 2019-12-24 JP JP2019232193A patent/JP6891257B2/ja active Active
-
2021
- 2021-08-09 US US17/397,870 patent/US20220098281A1/en active Pending
- 2021-10-08 AU AU2021245202A patent/AU2021245202A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112016003082A8 (pt) | uso da tropoelastina na produção de um medicamento para cicatrização de uma ferida ou para melhora da reepitelização de uma ferida | |
MX2019004616A (es) | Métodos de uso de indazol-3-carboxamidas y su uso como inhibidores de la ruta de señalización de wnt/b-catenina. | |
CL2016000373A1 (es) | Beneficio de supervivencia en pacientes con tumores sólidos con niveles elevados de proteína c reactiva | |
BR112017007144A2 (pt) | ácido valproico ou um sal farmaceuticamente aceitável do mesmo, composto, composição farmacêutica, e, composto ou composição para uso, uso, método ou composição. | |
BR112015020804A2 (pt) | dispositivo fototerapeutico, método e uso | |
MX353942B (es) | Sistemas para el cuidado de la piel después del procedimiento, composiciones y métodos de uso de los mismos. | |
BR112015023987A2 (pt) | creme dental de duas fases | |
BR112014006455A2 (pt) | alquilamidotiazóis, preparações cosméticas ou dermatológicas com um teor de um ou vários alquilamidotiazóis e uso de um ou vários alquilamidotiazóis | |
DOP2013000218A (es) | Anticuerpos monoclonales frente al inhibidor de la ruta del factor tisular (tfpi) | |
BR112015005369A2 (pt) | inibidores de usp30 e métodos para sua utilização | |
BR112013011845B8 (pt) | enxaguatório bucal compreendendo aminoácido básico e conservante e uso cosmético do enxaguatório bucal | |
BR112015026247A2 (pt) | métodos para o tratamento de câncer com o uso de terapia combinada com inibidor de cinase tor | |
BR112015027477A2 (pt) | método para tratamento de um transtorno de deglutição | |
BR112015026388A2 (pt) | métodos e composições para cicatrização de feridas | |
EA201592073A1 (ru) | Фармацевтические композиции, содержащие коллаген и гиалуронат натрия | |
EA201690854A1 (ru) | Фармацевтические композиции с гидратирующим и смазывающим действием | |
BR112018012749A2 (pt) | composições para higiene pessoal | |
BR112014000795A2 (pt) | uso cosmético e/ou dermatológico de compostos oligossacarídeos na prevenção e no tratamento de estrias | |
BR112016028895A2 (pt) | composições biofotônicas termofixas e usos destas | |
BR112015027992A2 (pt) | uso de ácido petroselínico para combater desordens estéticas da figura do corpo | |
AR097678A1 (es) | Composición para el cuidado oral que comprende un gel diluido de alginato de sodio y calcio | |
DOP2015000175A (es) | Uso de un péptido natriurético, un péptido diurético o un péptido vasodilatador en la elaboración de un medicamento para tratar una condición cardiovascular | |
BR112015024920A2 (pt) | associação sinérgica da alanina-glutamina, o ácido hialurônico e um extrato de aveia e sua utilização em uma composição destinada à cicatrização e o reparo das lesões cutâneas | |
TR201905218T4 (tr) | Nörodejenerati̇f hastaliklarin tedavi̇si̇ i̇çi̇n yararli vi̇tanoli̇dler. | |
BR112015028367A2 (pt) | modulação de atividade de fator de crescimento epidérmico de ligação de heparina para cura de membrana de tímpano |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: ALLERGAN AUSTRALIA PTY LTD (AU) |
|
B25A | Requested transfer of rights approved |
Owner name: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (IE) |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] |